Actelion Pharmaceuticals, Ltd. v. Matal

Lourie, Circuit Judge.

Actelion Pharmaceuticals, Ltd. (“Actel-ion”) appeals from the grant of summary judgment by the United States District Court for the Eastern District of Virginia in favor of the United States Patent and Trademark Office (“PTO”) regarding the length of the patent term adjustment (“PTA”) for U.S. Patent 8,658,675 (“the ’675 patent”), entitled “Pyridin-4-yl Derivatives.” See Aetelion Pharm., Ltd. v. Lee, 216 F.Supp.3d 680 (E.D. Va. 2016). For the reasons that follow, we affirm.

Background

Congress has established a framework in 35 U.S.C. § 154 (2012) to adjust a patent’s term…